HUMANA, INC. for HUMANA INC

Medicare/Medicaid MMM

Medicare Advantage (MA) Policy and Reimbursement Announcement of Calendar Year (CY) 2024 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies Medicare Part D Issues Medicaid Policy Issues Including Redeterminations and Dual Eligibles Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Home Health Policy and Reimbursement Issues Prescription Drug Rebate Issues Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act (117th Congress) Prior Authorization Policy and Regulatory Issues Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing (RIN 0955-AA03) CMS Guidance on Direct Negotiation (Official Title: Medicare Drug Price Negotiation Program: Initial Memorandum, Implementation of Sections 1191 - 1198 of the Social Security Act for Initial Price Applicability Year 2026, and Solicitation of Comments) CMS-4185-F2 Medicare Advantage Risk Adjustment Data Validation Final Rule Primary Care and Value-Based Care Policy and Reimbursement Clinical Policy Issues Including Workforce and Mental Health FY 2024 Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) Final Rule (CMS-1785-F and CMS-1788-F) Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Proposed Rule (CMS 1793-P) H.R. 4822, Health Care Price Transparency Act of 2023 Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Plan Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly, and Health Information Technology Standards (CMS-4205-P) CY 2024 Home Health Prospective Payment System Final Rule (CMS-1780-F) CY 2024 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Final Rule (CMS 1786-FC) CY 2024 Medicare Physician Fee Schedule Final Rule (CMS-1784-F) Hospital Outpatient Prospective Payment System (OPPS): Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Final Rule (CMS 1793-F)

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); SENATE; Office of Management & Budget (OMB)

Bills named: S. 3018 (118th), H.R. 4822 (118th), H.R. 3173 (118th)

Defense DEF

TRICARE Policy Issues including Telehealth, Value-Based Care, and T-5 Transition NDAA Implementation Policy Issues Veterans Healthcare and Policy Issues Implementation of National Defense Authorization Act for Fiscal Year 2024 Public Law No: 118-31

Contacted: Defense, Dept of (DOD); SENATE; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA)

Taxation/Internal Revenue Code TAX

Tax Reform Implementation Issues

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office; Treasury, Dept of

Pharmacy PHA

Prescription drug pricing Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Prescription Drug Rebate Issues

Contacted: White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)